Reliability of echocardiographic assessment of left ventricular structure and function: The PRESERVE study

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1625-1632

  Palmieri, Vittorio ^a   Dahlöf, Björn ^b   DeQuattro, Vincent ^c   Sharpe, Norman ^d   Bella, Jonathan N ^a   De Simone, Giovanni ^a   Paranicas, Mary ^a   Fishman, Dawn ^a   Devereux, Richard B ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ARTICLE; BODY MASS; CLINICAL TRIAL; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RELIABILITY;

AGED; FEMALE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 0033230761     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00396-4     Document Type: Article

References (34)

1. Levy D., Garrison R.T., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 332:1990;1561-1566.
2. Koren M.J., Devereux R.B., Casale P.N., et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 114:1991;345-352.
3. Mensah G.A., Koren M.J., Ulin R., et al. Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complication in essential hypertension. J Hypertens. 11:1993;1429-1440.
4. Verdecchia P., Porcellati C., Schillaci G., et al. Ambulatory blood pressure an independent predictor of prognosis in arterial hypertension . Hypertension. 24:1994;793-801.
5. Bikkina M., Levy D., Evans J.C., et al. Left ventricular mass and the risk of stroke in an elderly cohort the Framingham Heart Study . JAMA. 272:1994;33-36.
6. Liao Y., Cooper R.S., McGee D.L., et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 273:1995;1592-1597.
7. Devereux R.B., Roman M.J. Hypertensive cardiac hypertrophy pathophysiologic and clinical characteristics . Laragh J.H., Brenner B.M., Hypertension Pathophysiology, Diagnosis and Management . 2nd ed. 1995;409-424 Raven Press, New York.
8. Devereux R.B., Alderman M.H. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 88:1993;1444-1455.
9. Levy D., Labib S.B., Anderson K.M., et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 81:1990;815-820.
10. Woythaler J.N., Singer S.L., Kwan O.L., et al. Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy comparison with postmortem mass measurements . J Am Coll Cardiol. 2:1983;305-311.
11. Gottdiener J.S., Livengood S.V., Meyer P.A., Chase G.A. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 25:1995;424-430.
12. Wallerson D.C., Devereux R.B. Reproducibility of echocardiographic left ventricular measurements. Hypertension. 9:1987;II-6-II-8.
13. Devereux R.B., Dahlof B. Criteria for and informative trial of left ventricular hypertrophy regression. J Hum Hypertens. 8:1994;735-739.
14. de Simone G., Ganau A., Verdecchia P., Devereux R.B. Echocardiography in arterial hypertension when, why and how? J Hypertens. 12:(10):1994;1129-1136.
15. Gottdiener J.S. Hypertension left ventricular hypertrophy, hypertensive heart disease and the impact of echocardiographic data on treatment options, prognosis and assessment of therapy . Otto C.M., The Practice of Clinical Echocardiography. 1997;521-546 W.B. Saunders, Philadelphia.
16. Verdecchia P., Schillaci G., Borgioni C., et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation. 97:1998;48-54.
17. Davis C.E. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol. 104:1976;493-498.
18. Fleiss J.L. The Design and Analysis of Clinical Experiments. 1986;5-12 Wiley, New York.
19. Herpin D., Demange J. Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass quantification and clinical implication . Am J Hypertens. 7:1994;824-828.
20. Devereux R.B., Dahlof B., Levy D., Pfeffer M.A. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE Trial). Am J Cardiol. 78:1996;61-65.
21. Ghali J.K., Liao Y., Simmons B., et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary heart disease. Ann Intern Med. 117:1992;831-836.
22. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
23. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
24. Devereux R.B., Alosnso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings . Am J Cardiol. 57:1986;450-458.
25. de Simone G., Devereux R.B., Roman M.J., et al. Assessment of left ventricular function by the midwall fractional shortening-end-systolic stress relation in human hypertension. J Am Coll Cardiol. 23:1994;1444-1451.
26. Bland M.J., Altman D.G. Statistical method for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307-310.
27. Dahlof B., Wachtell K., Devereux R.B., et al. Change of left ventricular geometric pattern after one year of antihypertensive treatment the LIFE Study (abstr) . J Am Coll Cardiol. 23:1999;227A.
28. Landis J.R., Koch G.C. The measurement of observer agreement for categorical data. Biometrics. 33:1977;159-174.
29. Reichek N. Standardization in measurement of left ventricular wall mass two-dimensional echocardiography . Hypertension. 9:1987;II-30-II-32.
30. Collins H.W., Kronenberg M.W., Byrd B. III. Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography. J Am Coll Cardiol. 14:1989;672-676.
31. Himelman R.B., Cassidy M.M., Landzberg J.S., Schiller N.B. Reproducibility of quantitative two-dimensional echocardiography. Am Heart J. 115:1988;425-431.
32. Schiller N.B. Considerations in the standardization of measurement of left ventricular myocardial mass by two-dimensional echocardiography. Hypertension. 9:1987;II-33-II-5.
33. Devereux R.B., Agabiti-Rosei E., Dahlof B., et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens. 14:(Suppl 2):1996;S95-S102.
34. de Simone G., Ganau A., Verdecchia P., Devereux R.B. Echocardiography in arterial hypertension when, why and how? J Hypertens. 12:1994;1129-1136.